Gestational Trophoblastic Disease

On this page

GTD Basics - Trophoblast Trouble

  • Definition: Gestational Trophoblastic Disease (GTD): spectrum of proliferative disorders from placental trophoblast.
  • Spectrum & Classification:
    • Benign (Molar Pregnancies):
      • Hydatidiform Mole: Complete (CM), Partial (PM)
    • Malignant (Gestational Trophoblastic Neoplasia - GTN):
      • Invasive Mole
      • Choriocarcinoma
      • Placental Site Trophoblastic Tumor (PSTT)
      • Epithelioid Trophoblastic Tumor (ETT)
  • Epidemiology:
    • Incidence: ↑ in Asian countries (India: ~1/350-400 pregnancies).
    • Age extremes: <20 yrs, >40 yrs.
  • Risk Factors:
    • Prior GTD (strongest)
    • Advanced Maternal Age (AMA >35 yrs)
    • Advanced Paternal Age (APA >45 yrs)
    • History of infertility, prior spontaneous abortions
    • Diet: ↓ carotene/Vitamin A, ↓ animal fat.

⭐ The risk of a repeat molar pregnancy is ~1-2%; after two molar pregnancies, risk ↑ to 15-20%.

Molar Pregnancy - Grape Expectations

📌 Complete Mole: Chromosomes Completely Paternal, Can't grow fetus, Crazy hCG levels.

Hydatidiform moles are characterized by abnormal trophoblastic proliferation. Key differences distinguish complete and partial moles:

FeatureComplete MolePartial Mole
Karyotype46,XX (all paternal)Triploid (e.g., 69,XXY, diandric)
Fetus/AmnionAbsentPresent (often IUGR, anomalous)
Villous EdemaDiffuse, markedFocal, less marked
Trophoblastic Prolif.DiffuseFocal, slight
p57kip2NegativePositive
hCG LevelsVery ↑ (often >100,000 mIU/mL)Moderately ↑
USG'Snowstorm', no fetus, theca lutein cysts'Swiss cheese' placenta, fetus (may be IUGR)
ClinicalUterus > dates, ↑hCG effects (pre-eclampsia <20wks)Missed abortion, uterus < dates or normal
Malignant PotentialHigher (~15-20%)Lower (~1-5%)

⭐ p57kip2 immunostaining: Negative in complete moles (no maternal DNA to express p57), positive in partial moles (maternal DNA present).

Malignant GTD (GTN) - When Moles Go Rogue

Gestational Trophoblastic Neoplasia (GTN) encompasses malignant forms of GTD:

  • Invasive Mole
    • Myometrial invasion by hydropic villi.
    • Persistent ↑ hCG post-evacuation.
    • Metastases (lungs, vagina); often regresses.
  • Choriocarcinoma
    • Pure epithelial malignancy (cytotrophoblasts & syncytiotrophoblasts); NO villi.
    • Extensive necrosis; early hematogenous spread (lungs, brain, liver, kidney, vagina).
    • Highly chemosensitive.
    • Follows mole, abortion, ectopic, or term pregnancy.

    ⭐ Choriocarcinoma is the GTN most likely to metastasize to the brain.

  • Placental Site Trophoblastic Tumor (PSTT)
    • Neoplasm of intermediate trophoblasts at implantation site.
    • Produces hPL, low hCG levels.
    • Relatively chemoresistant; presents with amenorrhea/irregular bleeding.
  • Epithelioid Trophoblastic Tumor (ETT)
    • Rare; from chorionic-type intermediate trophoblasts.
    • Often discrete nodule; indolent or aggressive.

Diagnosis, Staging & Management - Charting the Course

  • Diagnosis (Post-Molar GTN Criteria):
    • hCG plateau (4 values, ±10%) >3 wks
    • hCG ↑ (≥10%, 3 values) >2 wks
    • hCG persists 6 months post-evac
    • Histology (Choriocarcinoma/PSTT/ETT) or Metastases
  • FIGO Anatomical Staging (2000):
    • I: Confined to uterus
    • II: Extends to genital structures (outside uterus)
    • III: Lung metastases
    • IV: Other distant metastases (e.g., brain, liver)
  • WHO Prognostic Scoring System: 📌 'A PALM SSite Chemo' (Age, Pregnancy antecedent, Interval from index pregnancy, pre-treatment hCG Level, Largest tumor size, Metastases site/number, Site of mets, Previous Chemo).
    • Score: ≤6 = Low-risk
    • Score: ≥7 = High-risk

    ⭐ The WHO prognostic scoring system is crucial for stratifying GTN patients into low-risk and high-risk groups, guiding chemotherapy selection.

  • Management & Follow-up Flow:
  • Key Management Points: Suction evacuation for molar pregnancy. Hysterectomy for chemoresistance or PSTT/ETT. Brain/Liver metastases may require specific therapy (e.g., radiotherapy, intrathecal chemo).
  • Follow-up: Serial hCG monitoring (weekly until normal for 3 consecutive weeks, then monthly for 6-12 months). Effective contraception during follow-up period.

High‑Yield Points - ⚡ Biggest Takeaways

  • Complete mole: 46,XX (all paternal), "snowstorm" USG, very high β-hCG, ↑ malignancy risk (choriocarcinoma).
  • Partial mole: Triploid (e.g., 69,XXY), often has fetal parts, lower β-hCG, ↓ malignancy risk.
  • Choriocarcinoma: Most aggressive GTD, early hematogenous spread (commonly lungs, vagina); treat with chemotherapy.
  • Serial β-hCG monitoring: Crucial for diagnosis, assessing treatment response, and detecting persistent GTD/GTN.
  • Suction evacuation is the standard primary treatment for molar pregnancies.
  • Gestational Trophoblastic Neoplasia (GTN) requires chemotherapy; FIGO staging guides management decisions for GTN.

Practice Questions: Gestational Trophoblastic Disease

Test your understanding with these related questions

Possible conversion to choriocarcinoma after hydatidiform mole is denoted by all of the following, except:

1 of 5

Flashcards: Gestational Trophoblastic Disease

1/10

_____ is an abnormal conception characterized by swollen and edematous chorionic villi with proliferation of trophoblasts only

TAP TO REVEAL ANSWER

_____ is an abnormal conception characterized by swollen and edematous chorionic villi with proliferation of trophoblasts only

Hydatidiform mole

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial